Investigator-Initiated Early Phase Clinical Trials of Natural Products (R61/R33 Clinical Trial Required)
Department of Health and Human Services ▸ National Institutes of Health ▸
Description
This grant opportunity funds early-stage clinical trials for natural products like botanicals, probiotics, and dietary supplements, provided they have a sound scientific basis. The first phase (R61) offers up to three years of funding to study how these products are absorbed and processed in the body. If certain goals are met, a second phase (R33) offers up to three more years to further test and refine the product's effects.
This NOFO supports early phase clinical trials of natural products, including botanicals, probiotics, and dietary supplements, with a strong scientific premise. The trials should provide high scientific utility and support further development or testing. The R61 phase offers up to three years of…
Source
Grant ID
PAR-25-269
Funding Source
Department of Health and Human Services ▸ National Institutes of Health ▸
Key Dates
Opportunity Released
December 2, 2024
Eligibility
The following categories of applicants are invited to apply:
- Regional Organizations
- U.S. Territories or Possessions
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Higher Education Institutions – Public/State Controlled Institutions of Higher Education
- Higher Education Institutions – Private Institutions of Higher Education
- Nonprofits (other than Institutions of Higher Education) – with 501(c)(3) IRS status
- Nonprofits (other than Institutions of Higher Education) – without 501(c)(3) IRS status
- For-Profit Organizations (Other than Small Businesses)
- Small Businesses
- Local Governments (general)
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Federal Government Agencies (Eligible Agencies of the Federal Government)
- Faith-based or Community-based Organizations
Awards & Funding
Total Funding
$350,000
Award Ceiling
$350,000
Funding Amount
~$350,000
Similar opportunities
- Investigator-Initiated Multi-Site Clinical Trials of Natural Products (UG3/UH3 Clinical Trial Required)
- Notice of Funding Opportunity Purpose
- Investigator-Initiated Mid-Phase Clinical Trials of Natural Products
- Notice of Funding Opportunity (NOFO) for Phase 1 Clinical Trials for HLBS Disorders
- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)